The proposed sale is small relative to the company's market cap and appears to be a routine diversification move by an officer following a restricted stock vesting. No immediate read-through for the stock; monitor for any subsequent Form 4 filings to confirm execution.
Price Chart
Executive Summary
Renee D. Gala, an officer of Jazz Pharmaceuticals, filed a Form 144 notice of intent to sell 2,000 common shares with an estimated aggregate market value of approximately $472,800. The shares were acquired via restricted stock vesting on June 30, 2026. The filing is a routine advance notice of a planned sale by an insider and does not indicate any material change in the company's fundamentals or outlook.
Key Facts
- Insider: Renee D. Gala (Officer)
- Shares to be sold: 2,000 common shares
- Estimated market value: ~$472,800
- Shares acquired via restricted stock vesting on June 30, 2026
- Filing date: October 6, 2026
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
Financial Impact
~$472,800 sale value, representing a small fraction of the issuer's market cap
Risk Factors
- Insider sale may be executed at any time, potentially creating modest selling pressure
- No material risk to the company's operations or financial position
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-010067 |
| Document: 0001950047-26-010067-index.html | 0001950047-26-010067 |
| Document: 0001950047-26-010067.txt | 0001950047-26-010067 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 6d ago | Press Release | $213.76 $211.97 | ▼ −0.84% | ▼ −1.36% | $210.99 (−1.30%) |
Oct 9, 2026 17d ago | 8-K | $218.42 $216.75 | ▼ −0.76% | ▼ −0.70% | $210.99 (−3.40%) |
Oct 8, 2026 17d ago | 144 | $218.42 $216.75 | ▼ −0.76% | ▼ −0.70% | $210.99 (−3.40%) |
Oct 6, 2026 19d ago | 144 | $231.19 $222.45 | ▼ −3.78% | ▼ −3.36% | $210.99 (−8.74%) |
Oct 1, 2026 24d ago | 144 | $235.67 $236.04 | ▲ +0.16% | ▼ −0.52% | $210.99 (−10.47%) |
Sep 15, 2026 5w ago | 8-K | $240.83 $243.59 | ▲ +1.15% | ▲ +1.59% | $210.99 (−12.39%) |
Sep 14, 2026 5w ago | Insider Cluster | $240.83 $243.59 | ▲ +1.15% | ▲ +1.59% | $210.99 (−12.39%) |
Sep 10, 2026 6w ago | Insider Cluster | $245.80 $245.87 | ▲ +0.03% | ▲ +0.47% | $210.99 (−14.16%) |
Sep 2, 2026 7w ago | Insider Cluster | $247.57 $246.81 | ▲ +0.30% | ▼ −0.08% | $210.99 (+14.78%) |
Aug 31, 2026 7w ago | 144 | $243.71 $245.57 | ▲ +0.76% | ▲ +0.32% | $210.99 (−13.43%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers